Announcement
01 Dec 2025
In December 2025, the U.S. Administration announced its commitments under an agreement on pharmaceutical pricing with the United Kingdom.
Source
Number of interventions
1
0 certainly harmful
1 likely harmful
0 liberalising
Implementation date
No implementation date
Revocation date:
No revocation date
Announced: 01 Dec 2025
United Kingdom: UK Government’s commitments under an agreement on pharmaceuticals with the United States
Announced: 08 May 2025
United States of America: US Administration's commitments under "Economic Prosperity Deal" with the United Kingdom
Announced: 08 May 2025
United Kingdom: UK Government's commitments under "Economic Prosperity Deal" with the United States
Implemented: 02 Apr 2026
United States of America: U.S. Administration imposes Section 232 tariffs on pharmaceutical imports
See all
This Thread tracks harmful trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
70619
194
This Thread tracks global import restrictions affecting a wide range of chemicals from rare gases to biodiesel. Focusing solely on interventions classified as import restrictions by Global Trade Alert, it highlights how the yearly number of these measures has evolved since 2009. Discover key trends, significant figures, and the countries most impacted by these policies in this comprehensive overvi...
Published: 09 Jan 2025
905
133
This Thread tracks global import and export restrictions affecting critical minerals. It covers policy interventions affecting these measures since 2009. Relevant interventions are identified based on intervention type and specific HS codes. Note that the GTA focuses on a compilation list of all the critical minerals mentioned in different national lists to identify relevant HS codes.
Published: 31 Jan 2025
1442
124
This Thread tracks the U.S. Administration’s agreements with pharmaceutical companies. It is based on the Executive Order titled “Delivering Most-Favored-Nation (MFN) Prescription Drug Pricing to American Patients.” These agreements include tariff relief measures for pharmaceutical companies in return for their commitments to implement most-favored-nation pricing for their drugs and to invest i...
Published: 11 Nov 2025
68
2